Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial
Juan F. Iglesias, Marco Roffi, Sylvain Losdat, Olivier Müller, Sophie Degrauwe, David J. Kurz, Laurent Haegeli, Daniel Weilenmann, Christoph Kaiser, Maxime Tapponnier, Stéphane Cook, Florim Cuculi, Dik Heg, Stephan Windecker, Thomas Pilgrim
Topics & Concepts
MedicineSirolimusPercutaneous coronary interventionEverolimusTarget lesionMyocardial infarctionStentClinical endpointHazard ratioSurgeryInternal medicineCardiologyRandomized controlled trialConfidence intervalCoronary Interventions and DiagnosticsAcute Myocardial Infarction ResearchCardiac Valve Diseases and Treatments